Literature DB >> 2138543

Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.

F Brunet1, G Vedel, F Dreyfus, J F Vaxelaire, T Giraud, B Schremmer, J F Monsallier.   

Abstract

A report is given on two neutropenic patients with staphylococcal septicemia caused by Staphylococcus haemolyticus and Staphylococcus aureus (both strains methicillin-resistant) who failed to respond to therapy with teicoplanin. Both strains were resistant to teicoplanin (MIC 16 and 8 mg/l respectively), but remained sensitive to vancomycin (MIC 2 and 4 mg/l respectively). Replacement of teicoplanin with vancomycin led to full recovery of both patients and their discharge from hospital. These two cases emphasize the importance of clinical and microbiological monitoring of patients with staphylococcal septicemia, even when glycopeptides are used for treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138543     DOI: 10.1007/bf01963643

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

Review 1.  Infection in bone marrow transplant recipients.

Authors:  J D Meyers
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

2.  LY146032: activity and resistance development in vitro.

Authors:  R P Mouton; S L Mulders
Journal:  J Antimicrob Chemother       Date:  1987-10       Impact factor: 5.790

3.  In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.

Authors:  E P Moore; D C Speller
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

4.  Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

5.  Emergence of vancomycin resistance in coagulase-negative staphylococci.

Authors:  R S Schwalbe; J T Stapleton; P H Gilligan
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

6.  Teicoplanin-resistant coagulase-negative staphylococcus.

Authors:  A P Wilson; M D O'Hare; D Felmingham; R N Grüneberg
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

7.  Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.

Authors:  D E Low; A McGeer; R Poon
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 8.  Synergistic combinations of antibiotics in gram-negative bacillary infections.

Authors:  J Klastersky; S H Zinner
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

Review 9.  Infectious complications of human bone marrow transplantation.

Authors:  D J Winston; R P Gale; D V Meyer; L S Young
Journal:  Medicine (Baltimore)       Date:  1979-01       Impact factor: 1.889

10.  Bacteremia and fungemia in patients with neoplastic disease.

Authors:  E Whimbey; T E Kiehn; P Brannon; A Blevins; D Armstrong
Journal:  Am J Med       Date:  1987-04       Impact factor: 4.965

View more
  17 in total

Review 1.  Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.

Authors:  Catherine Liu; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

2.  Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid.

Authors:  M Souli; K Pontikis; Z Chryssouli; I Galani; H Giamarellou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

3.  Clinical efficacy of teicoplanin.

Authors:  P Calain; F Waldvogel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

4.  Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.

Authors:  G Vedel; M Leruez; F Lémann; E Hraoui; D Ratovohery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

Review 5.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital.

Authors:  F Guerin; A Buu-Hoï; J L Mainardi; G Kac; N Colardelle; S Vaupré; L Gutmann; I Podglajen
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus.

Authors:  K Sieradzki; A Tomasz
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

Review 8.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

9.  Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.

Authors:  F Menichetti; P Martino; G Bucaneve; G Gentile; D D'Antonio; V Liso; P Ricci; A M Nosari; M Buelli; M Carotenuto
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 10.  Update on clinical significance of coagulase-negative staphylococci.

Authors:  W E Kloos; T L Bannerman
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.